This federal contract award, identified as SPE2DH14D0003|8304, was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $75,392.15 fixed-price contract with economic price adjustment is for the provision of a PROXIMAL TENODESIS IMPLANT SYSTEM REV, delivered under the DLA Medical Capital Equipment Program. The contract does not have a set-aside designation, indicating Arthrex's competitive position in the open federal market. In addition to this award, Arthrex holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $471,048,172.66, which allows VA medical centers nationwide to acquire Arthrex's innovative orthopedic technologies through task orders. The company's federal contract portfolio demonstrates its ability to efficiently support government healthcare systems with specialized orthopedic solutions tailored to meet the diverse medical needs of veterans and military personnel.